CJC-1295 with DAC is a synthetic 30-amino-acid analogue of growth hormone-releasing hormone, incorporating a drug affinity complex modification at the C-terminus. It is supplied here as a lyophilised powder in a sealed vial in 5mg and 10mg quantities.
This listing is for the compound as an analytical and research material. No application, effect or property in humans or animals is stated or implied.
Background
Growth hormone-releasing hormone is a 44-amino-acid peptide; its first 29 residues represent the biologically characterised core sequence, and a number of synthetic analogues of that region have been produced for laboratory work. CJC-1295 with DAC carries an additional drug affinity complex modification which distinguishes it structurally from the unmodified analogue supplied separately on this site.
It is not a licensed medicine in the United Kingdom and holds no marketing authorisation. It is not a controlled substance under the Misuse of Drugs Act 1971.
For structural detail, published literature and citations, see the compound reference entry: /compounds/cjc-1295-with-dac/
There are no reviews yet.